INKTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
MiNK Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$9.56+0.15 (+1.59%)
Close on Oct 19, 2026
- Market cap
- $48.02M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of MiNK Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 13, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 13, 2026 | Aug 13, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 17, 2026 | Jun 23, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 15, 2026 | SEC EDGAR |
| Current report | 8-K | May 15, 2026 | May 15, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 17, 2026 | Apr 30, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 31, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 31, 2026 | Mar 31, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 27, 2026 | Mar 27, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 13, 2026 | Mar 19, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 29, 2025 | Jan 2, 2026 | SEC EDGAR |
| Current report | 8-K | Nov 14, 2025 | Dec 8, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 14, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 23, 2025 | Sep 29, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 14, 2025 | Aug 14, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 14, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 15, 2025 | Jul 15, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 11, 2025 | Jul 14, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 18, 2025 | Jun 18, 2025 | SEC EDGAR |
| Current report | 8-K | May 15, 2025 | May 15, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 15, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Dec 31, 2024 | Apr 30, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 18, 2025 | Mar 18, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 18, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 17, 2025 | Jan 21, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jan 17, 2025 | Dec 20, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 14, 2024 | Nov 14, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 14, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 30, 2024 | Oct 31, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 15, 2024 | Oct 18, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 13, 2024 | Sep 13, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 27, 2024 | Aug 30, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 13, 2024 | Aug 13, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 13, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 12, 2024 | Jun 17, 2024 | SEC EDGAR |
| Current report | 8-K | May 13, 2024 | May 16, 2024 | SEC EDGAR |
| Current report | 8-K | May 14, 2024 | May 14, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 14, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Dec 31, 2023 | Apr 29, 2024 | SEC EDGAR |
| Current report | 8-K | Mar 21, 2024 | Mar 21, 2024 | SEC EDGAR |